IL6R and rheumatoid arthritis: Tocilizumab is a monoclonal antibody against IL-6R including sIL-6R and IL-6/sIL-6R complex (Table 3) [205] and it has been approved for the treatment of rheumatoid arthritis and cytokine release syndrome [206].